Wednesday, 7 June 2017

Reducing animal testing in Europe

The European Medicines Agency has produced a position paper titled “Reflection paper providing an overview of the current 4 regulatory testing requirements for medicinal products for 5 human use and opportunities for implementation of the 6 3Rs.” The reference is: EMA/CHMP/CVMP/JEG-3Rs/742466/2015

This relates to regulatory acceptance of 3R 29 (replacement, reduction, refinement) testing approaches (EMA/CHMP/CVMP/JEG-3Rs/450091/2012). 30 The current reflection paper has been developed as a follow up to that draft guideline and provides an 31 overview of the main animal tests required for the regulatory testing of medicinal products for human 32 use (a parallel document has been developed in relation to veterinary medicinal products – 33 EMA/CHMP/CVMP/JEG-3Rs/740772/2015). It includes information on opportunities for limiting animal 34 testing that can already be implemented, where appropriate, as well as information on opportunities 35 that may become available in the future. In so doing, it is hoped that the document may stimulate 36 future submissions for CHMP advice on the regulatory acceptance of new 3Rs approaches.

Posted by Dr. Tim Sandle